Literature DB >> 31967362

Organizational readiness to implement population-based screening and genetic service delivery for hereditary cancer prevention and control.

Sarah Knerr1, Kathleen M West2, Frank A Angelo1.   

Abstract

Despite clinical guidelines, programs conducting population-based screening and genetic service delivery for hereditary cancer prevention and control are rare in practice. We interviewed individuals (n = 13) instrumental in implementing seven unique clinical programs conducting either universal tumor screening for Lynch Syndrome or routine family history screening and provision of genetic services for hereditary breast and ovarian cancer in the United States. To characterize determinants of readiness to implement population-based cancer genetic service delivery models, interviews and deductive codes drew on Weiner's theory of organizational readiness for change. Qualitative analysis identified themes across programs. The degree to which organizational stakeholders valued moving to a population-based genetic service delivery model depended on the existence of aligned clinical guidelines at the time of program implementation. However, judgments of implementation capacity within the organization, particularly with respect to task demands and resource concerns, were more often barriers to readiness. Program champions were essential to facilitating readiness, frequently taking on substantial uncompensated work. These data suggest that developing interventions targeting change efficacy and cultivating practice change champions may be two promising ways to increase uptake of population-based hereditary cancer screening and genetic service delivery in clinical practice.
© 2020 National Society of Genetic Counselors.

Entities:  

Keywords:  guideline implementation; hereditary cancer syndromes; organizational readiness for change; population screening; risk assessment; service delivery models

Mesh:

Year:  2020        PMID: 31967362      PMCID: PMC9235414          DOI: 10.1002/jgc4.1216

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.717


  32 in total

Review 1.  American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Lynch Syndrome.

Authors:  Joel H Rubenstein; Robert Enns; Joel Heidelbaugh; Alan Barkun
Journal:  Gastroenterology       Date:  2015-07-27       Impact factor: 22.682

2.  Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.

Authors:  Anne Marie McCarthy; Mirar Bristol; Susan M Domchek; Peter W Groeneveld; Younji Kim; U Nkiru Motanya; Judy A Shea; Katrina Armstrong
Journal:  J Clin Oncol       Date:  2016-05-09       Impact factor: 44.544

3.  NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

Authors:  Mary B Daly; Robert Pilarski; Michael Berry; Saundra S Buys; Meagan Farmer; Susan Friedman; Judy E Garber; Noah D Kauff; Seema Khan; Catherine Klein; Wendy Kohlmann; Allison Kurian; Jennifer K Litton; Lisa Madlensky; Sofia D Merajver; Kenneth Offit; Tuya Pal; Gwen Reiser; Kristen Mahoney Shannon; Elizabeth Swisher; Shaveta Vinayak; Nicoleta C Voian; Jeffrey N Weitzel; Myra J Wick; Georgia L Wiesner; Mary Dwyer; Susan Darlow
Journal:  J Natl Compr Canc Netw       Date:  2017-01       Impact factor: 11.908

4.  Implementation in a large health system of a program to identify women at high risk for breast cancer.

Authors:  William L Owens; Thomas J Gallagher; Michael J Kincheloe; Victoria L Ruetten
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

Review 5.  Public health action in genomics is now needed beyond newborn screening.

Authors:  M S Bowen; K Kolor; W D Dotson; R M Ned; M J Khoury
Journal:  Public Health Genomics       Date:  2012-09-11       Impact factor: 2.000

6.  Low Referral Rate for Genetic Testing in Racially and Ethnically Diverse Patients Despite Universal Colorectal Cancer Screening.

Authors:  Charles Muller; Sang Mee Lee; William Barge; Shazia M Siddique; Shivali Berera; Gina Wideroff; Rashmi Tondon; Jeremy Chang; Meaghan Peterson; Jessica Stoll; Bryson W Katona; Daniel A Sussman; Joshua Melson; Sonia S Kupfer
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-18       Impact factor: 11.382

7.  Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results.

Authors:  Laura C Beamer; Marcia L Grant; Carin R Espenschied; Kathleen R Blazer; Heather L Hampel; Jeffrey N Weitzel; Deborah J MacDonald
Journal:  J Clin Oncol       Date:  2012-02-21       Impact factor: 44.544

Review 8.  A systematic review of factors that act as barriers to patient referral to genetic services.

Authors:  Türem Delikurt; Graham R Williamson; Violetta Anastasiadou; Heather Skirton
Journal:  Eur J Hum Genet       Date:  2014-09-10       Impact factor: 4.246

Review 9.  Inside help: An integrative review of champions in healthcare-related implementation.

Authors:  Edward J Miech; Nicholas A Rattray; Mindy E Flanagan; Laura Damschroder; Arlene A Schmid; Teresa M Damush
Journal:  SAGE Open Med       Date:  2018-05-17

10.  A framework to build capacity for a reflex-testing program for Lynch syndrome.

Authors:  Vanessa N Palter; Natalie A Baker; Linda Rabeneck; Jill Tinmouth; Anna R Gagliardi; Erin D Kennedy; June C Carroll; Steven Gallinger; Nancy N Baxter
Journal:  Genet Med       Date:  2018-10-22       Impact factor: 8.822

View more
  2 in total

1.  Using Multilevel Structural Equation Modeling (MSEM) to Identify the Predictors and Influencing Mechanism of Technology Use Among Chinese Physicians: An Example from Des-Gamma-Carboxy Prothrombin (DCP).

Authors:  Qingwen Deng; Yueqin Wang; Wenbin Liu
Journal:  Risk Manag Healthc Policy       Date:  2022-01-18

2.  Personalized Approaches for the Prevention and Treatment of Breast Cancer.

Authors:  Hermann Nabi
Journal:  J Pers Med       Date:  2022-07-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.